Intellipharmaceutics International

Pharmaceutical Manufacturing · 11 Employees
Phone Number: 4167983001
Email Address: info@intellipharmaceutics.com
  • Overview
  • Employees
Access 30 Verified Employees Profiles for Intellipharmaceutics InternationalUnlock Free Contacts Now
About
At Intellipharmaceutics, we are engaged in the research, development and commercialization of pharmaceutical products, both novel and generic, with a particular emphasis in the controlled-release & opioid abuse deterrence space. Intellipharmaceutics also operates a contract analytical services lab in Toronto that provides Methods Development, Validation & Transfer, Quality Control Testing, Stability Testing and Category 1 Abuse Deterrent Studies. Intellipharmaceutics International is currently trading on the OTCQB and TSX (OTCQB: IPCIF; TSX: IPCI).
Year Founded
1998
Social Media
LinkedinFacebookTwitter
Industry
Pharmaceutical Manufacturing
HQ Location
30 Worcester Rd Etobicoke, ON M9W 5X2, CA
Keywords
Generic PharmaceuticalsControlled-Release Drug DeliveryHypermatrix (TM) TechnologyAbuse DeterrentAnalytical TestingQuality Control TestingCategory 1 Abuse Deterrent SutdiesAbuse Deterrent FormulationsContract Analytical Servicsand Stability Studies
Location
  • 30 Worcester Rd Etobicoke, ON M9W 5X2, CA

Email Formats

Sign up for free credits and discover verified email addresses of Intellipharmaceutics International
FormatExamples
first + last
andywarhol@intellipharmaceutics.com
first_initial + last
awarhol@intellipharmaceutics.com
first + last_initial
andyw@intellipharmaceutics.com
first
andy@intellipharmaceutics.com
last
warhol@intellipharmaceutics.com
Get Verified Emails for 30 Intellipharmaceutics International Employees

Frequently Asked Questions

Learn More about Intellipharmaceutics International

Similar Companies

Pharmaceutical Manufacturing

Get key business info for Intellipharmaceutics International and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.